BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11297251)

  • 1. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
    Gazzaniga P; Gandini O; Giuliani L; Magnanti M; Gradilone A; Silvestri I; Gianni W; Gallucci M; Frati L; Aglianò AM
    Clin Cancer Res; 2001 Mar; 7(3):577-83. PubMed ID: 11297251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
    Okegawa T; Kinjo M; Nutahara K; Higashihara E
    J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
    Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay.
    De Luca A; Pignata S; Casamassimi A; D'Antonio A; Gridelli C; Rossi A; Cremona F; Parisi V; De Matteis A; Normanno N
    Clin Cancer Res; 2000 Apr; 6(4):1439-44. PubMed ID: 10778975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers.
    Lukyanchuk VV; Friess H; Kleeff J; Osinsky SP; Ayuni E; Candinas D; Roggo A
    Anticancer Res; 2003; 23(3B):2711-6. PubMed ID: 12894563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
    Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
    Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
    Clarke LE; Leitzel K; Smith J; Ali SM; Lipton A
    Int J Oncol; 2003 Feb; 22(2):425-30. PubMed ID: 12527944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
    Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
    J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.
    Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM
    Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor.
    Leitzel K; Lieu B; Curley E; Smith J; Chinchilli V; Rychlik W; Lipton A
    Clin Cancer Res; 1998 Dec; 4(12):3037-43. PubMed ID: 9865918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of tumor circulating cells by cytokeratin 20 in the blood of patients with endometrial carcinoma.
    Klein A; Fishman A; Zemer R; Zimlichman S; Altaras MM
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):352-5. PubMed ID: 10985893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer.
    Gazzaniga P; Nofroni I; Gandini O; Silvestri I; Frati L; Aglianò AM; Gradilone A
    Oncol Rep; 2005 Nov; 14(5):1199-202. PubMed ID: 16211285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer.
    Fishman A; Klein A; Zemer R; Zimlichman S; Bernheim J; Cohen I; Altaras MM
    Gynecol Oncol; 2000 Jun; 77(3):399-404. PubMed ID: 10831349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CK20 gene expression: technical limits for the detection of circulating tumor cells.
    Champelovier P; Mongelard F; Seigneurin D
    Anticancer Res; 1999; 19(3A):2073-8. PubMed ID: 10470150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating cancer cells in human oral squamous cell carcinoma.
    Zen H; Nakashiro K; Shintani S; Sumida T; Aramoto T; Hamakawa H
    Int J Oncol; 2003 Sep; 23(3):605-10. PubMed ID: 12888894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic detection for hematogenous micrometastasis in patients with various types of malignant tumors using Uroplakin II derived primers in polymerase chain reaction.
    Hirata H; Hisatomi H; Kawakita M; Nagao K; Yamamoto S; Hikiji K; Nakamoto T; Harasawa H; Kaneko N; Matsuda T; Yamamoto M; Kanamaru T
    Oncol Rep; 2003; 10(4):963-6. PubMed ID: 12792753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
    Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
    Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.